Brief: Infinity Pharmaceuticals Reports Q1 2021 Financial Results And Provides Company Update
May 13 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS REPORTS FIRST QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES COMPANY UPDATE
* Q1 LOSS PER SHARE $0.15
* Q1 EARNINGS PER SHARE ESTIMATE $-0.12 -- REFINITIV IBES
DATA
* EXPECTS NET LOSS FOR 2021 TO RANGE FROM $40 MILLION TO $50
MILLION
* INFINITY - EXPECTS TO END 2021 WITH A YEAR-END-CASH, CASH
EQUIVALENTS AND AVAILABLE FOR SALE SECURITIES BALANCE RANGING
FROM $70 MILLION TO $80 MILLION
Source text for Eikon: ID:nBwbp72SVa
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX